INAB (IN8bio) SpecialCharges


INAB IN8bio Inc INAB
28 GF Score
Price $1.38
View Full Analysis

What is IN8bio SpecialCharges?

Special Charges only applies to banks.

INAB
28GF Score
IN8bio Inc INAB
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IN8bio Business Description

Address 350 5th Avenue, Suite 5330, New York, NY, USA, 10118
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
28GF Score

Get the complete analysis for INAB

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.38
Price